Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if post-operative stent size impacts stent-related pain and discomfort.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A: 4.8 Fr Ureteral stents | Experimental |
| |
| Group B: 7 Fr Ureteral stents | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 4.8 Fr Ureteral stents | Device | After surgery, patients will have the Boston Scientific 4.8 Fr ureteral stent placed. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain score post ureteroscopy procedure until stent removal determined by the primary operating team. Stent will be on a string | Post-operatively, patient will be contacted by study coordinators every day until stent is removed (usually 7-14 days after the surgery) to scale their stent pain on a scale from 1-5 as following: No pain: 1; Mild pain with no need for additional medication: 2; Mild pain with need for additional medication (anticholinergics): 3; Moderate stent pain (requiring narcotics): 4; Severe stent pain (requiring ER visit): 5. | Starting post-operatively, daily, until stent is removed (estimated 7-14 days) |
| Measure | Description | Time Frame |
|---|---|---|
| Volume of post-operative correspondence between patients and medical system. | Total number of communications received from patient post-operatively. | 14 days |
Not provided
Inclusion Criteria:
• Patients undergoing a retrograde intra-renal surgery (RIRS) (only patients undergoing the procedure for stone treatment will be included) who will require post-operative indwelling ureteral stent placement on a string at the conclusion of the procedure.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Meghan A. Cooper, DO | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 7 Fr Ureteral stents | Device | After surgery, patients will have the Bard 7 Fr ureteral stent placed. |
|